The Patient-in-Chief Will Affect How Americans See Covid’s Risk
(Bloomberg) -- In medicine, there's a saying: anecdote isn't data. But what happens when the world's most famous data point gets sick with Covid?
President Donald Trump has for months publicly downplayed the risk from the virus, eschewing the use of masks himself, among his staff and at his rallies. That's despite the fact that a prime vehicle for transmission is groups of people talking loudly in contained spaces — Washington in a nutshell.
Now he's sick. While Trump is in a higher-risk group because of his age and weight, he'll also receive the best medical care on the planet. How severe his illness is and how quickly he recovers is likely to have a huge impact on the public's perception of the disease and its risk.
On Friday morning, Fox & Friends co-host Brian Kilmeade, a regular booster of Trump, raised the possibility that if Trump gets better quickly, it may cause people to take the virus less seriously.
“There's a lot of people out there that say, ‘If I get it, I die,'” Kilmeade said on Fox. “What if the most famous person in the world gets it and in 10 days is back out? Doesn't that also send a message that you can say whatever you want in stats and graphs, but I give you an example of somebody who is in that danger age of 74, who is out there, gets it and beats it — could that also send a message?”
Public health is a profession of percentages. With an infection like Covid-19, the vast majority of people recover. Age, pre-existing illnesses, weight and other health factors can influence a patient's chances, but there's no perfect way to predict any one individual's outcome. Measures like mask-wearing and social distancing are meant to better the odds by getting fewer people sick and protecting the most vulnerable.
The “anecdote isn't data” saying is a direct reflection of that. Just because one person recovers from an illness, or responds to a drug, doesn't mean that everyone — or anyone — else will. Health professionals look at data from research, and base their advice to medical professionals and the public on the same.
“There is a genuine concern, and it's not an unreasonable concern, that in the event that the president was to experience only mild illness, then he might seek to use that as evidence to further suggest that this is not as serious as what it actually is,” said Adam Kamradt-Scott, who researches how governments and organizations deal with health challenges at the United States Studies Centre. “That would be unfortunate, would be the diplomatic way of putting it.”
More than 200,000 Americans have died of Covid-19, and many more have been hospitalized. Trump is having mild symptoms so far. Most cases stay relatively mild, and it will take several days to know how Trump's turns out.
“In many patients who do get very sick it happens around day eight to 10,” said Helen Boucher, chief of the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center.
Read more: How doctors would treat a patient like Trump
In past remarks, Trump has made clear that older Americans are at risk. “It affects elderly people, elderly people with heart problems, if they have other problems, that's what it really affects,” Trump said at a rally on Sept. 21.
But he's also downplayed the risk for others, particularly the young. “Take your hat off to the young because they have a hell of an immune system. It affects virtually nobody,” Trump said at the rally. “It's an amazing thing. By the way, open your schools!”
Others in his administration have done the same, such as his health adviser Scott Atlas, who has said that more Americans than other experts say may have some level of immunity to the virus.
Trump's political support is strongest with older Americans: An Aug. 13 study by the Pew Research Center found that 52% of registered voters over age 65 favored Trump, his best showing.
That same group is most at risk of death and hospitalization. According to the Centers for Disease Control and Prevention, people aged 65 to 74 are five times more likely to be hospitalized with the virus than people aged 18 to 29. Deaths in that group are higher as well: Out of 194,091 Covid-involved fatalities the CDC has counted in the U.S., 26% of them were in the 65-to-74 age group.
“This is a reminder that COVID-19 is an ongoing threat to our country and can happen to anyone,” said Tom Frieden, director of the CDC under the Obama administration and a frequent critic of Trump's response to the virus.
On Fox News, another of the network's hosts, Stuart Varney, raised a similar possible reaction from the public.
“The immediate reaction of a lot of people will be, ‘My goodness, if the president of the United States can get it, maybe I can, too.'”
©2020 Bloomberg L.P.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.